News & Updates

Show Multimedia Only
Tirzepatide beneficial for shedding pounds in obese adults

Tirzepatide beneficial for shedding pounds in obese adults

21 Jul 2022

Once-weekly treatment with tirzepatide in adults with obesity appears to yield substantial and sustained reductions in body weight, according to the phase III SURMOUNT-1 trial.

Tirzepatide beneficial for shedding pounds in obese adults

21 Jul 2022
Chronic hepatitis C tied to cardiovascular events in T2DM

Chronic hepatitis C tied to cardiovascular events in T2DM

19 Jul 2022

In patients with type 2 diabetes mellitus (T2DM), chronic hepatitis C and fatty liver appear to worsen the risk of cardiovascular events, a recent Taiwan study has found.

Chronic hepatitis C tied to cardiovascular events in T2DM

19 Jul 2022
Serum CTRP4 tied to coronary artery disease in T2DM

Serum CTRP4 tied to coronary artery disease in T2DM

17 Jul 2022

In patients with type 2 diabetes mellitus (T2DM), higher serum levels of circulating C1q tumour necrosis factor-related protein 4 (CTRP4) appear to aggravate the likelihood of coronary artery disease, a recent study has found.

Serum CTRP4 tied to coronary artery disease in T2DM

17 Jul 2022
Family history plus obesity/hyperglycaemia redoubles renal cell cancer risk

Family history plus obesity/hyperglycaemia redoubles renal cell cancer risk

16 Jul 2022